Ultrasound versus palpation‐guided corticosteroid injection for de Quervain disease: A randomized controlled trial
PM&R · 2024
DOI: 10.1002/pmrj.13144 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PM&R, 2024. Verfasst von Ying-Chen Kuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine & Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: De Quervain Disease, Palpation, Ultrasonography, Interventional, Pain Measurement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Shin Kong Wu Ho-Su Memorial Hospital, Shin Kong Hospital.
Abstract (Originalsprache)
Introduction
Corticosteroid injection effectively treats de Quervain disease, and due to the high prevalence of the intracompartmental septum in the first extensor compartment, ultrasound guidance improves injection accuracy.
Objective
To compare the effectiveness, adverse events, and the recurrence rate between ultrasound‐guided and palpation‐guided injection in patients with de Quervain disease.
Design
Prospective, single‐blind, randomized controlled trial.
Setting
Rehabilitation department of a private teaching hospital.
Participants
We enrolled 49 patients, ≥20 years of age, clinically diagnosed with de Quervain disease based on their medical history and physical examination.
Interventions
Patients were randomized into two groups: ultrasound‐guided and palpation‐guided injection. Both groups received a mixture of 10 mg triamcinolone acetonide (10 mg/1 mL) and 0.3 mL 1% lidocaine. Main Outcome Measures The primary outcome measure was the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) score at 1 week. The secondary outcome measures were visual analog scale for pain (pain VAS) score, patient satisfaction, and adverse events or complications from the interventions at 1 week, 3 months, and 6 months.
Results
Both groups showed improvement over time in QuickDASH scores and pain VAS ( p < .001); however, no statistically significant differences were noted between the groups for either QuickDASH scores ( p = .22) or pain VAS ( p = .30). In addition, no statistically significant differences were found between the groups in terms of patient satisfaction ( p = .76) and adverse events ( p = .47, .33, .58) at the 1‐week, 3‐month, and 6‐month follow‐ups.
Conclusions
Both ultrasound‐guided and palpation‐guided injections effectively treated de Quervain disease. During a 6‐month follow‐up, there were no statistically significant differences between the groups in pain relief, upper limb function, or patient satisfaction. However, the palpation‐guided group showed a tendency for more recurrence and skin side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physical Medicine & Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
- Administration Division, Research Department, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
ORCID-Profile: Lin-Fen Hsieh
Förderung
- Shin Kong Wu Ho-Su Memorial Hospital
- Shin Kong Hospital
Zitieren
APA
Kuo, Y. C., Hsieh, L. F., Liu, Y. F., & Chang, C. S. (2024). Ultrasound versus palpation‐guided corticosteroid injection for de Quervain disease: A randomized controlled trial. PM&R. https://doi.org/10.1002/pmrj.13144
Vancouver
Kuo YC, Hsieh LF, Liu YF, Chang CS. Ultrasound versus palpation‐guided corticosteroid injection for de Quervain disease: A randomized controlled trial. PM&R. 2024. doi:10.1002/pmrj.13144
BibTeX
@article{Kuo2024,
author = {Kuo, Ying-Chen and Hsieh, Lin-Fen and Liu, Ya-Fang and Chang, Chia-Sung},
title = {Ultrasound versus palpation‐guided corticosteroid injection for de Quervain disease: A randomized controlled trial},
journal = {PM&R},
year = {2024},
doi = {10.1002/pmrj.13144}
}
EUVIMED